ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1.

ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1.

Epithelial to mesenchymal transition (EMT), and the reverse mesenchymal to epithelial transition (MET), are known examples of epithelial plasticity that are important in kidney development and cancer metastasis. Here we identify ASPP2, a haploinsufficient tumour suppressor, p53 activator and PAR3 bi...

Full description

Bibliographic Details
Main Authors:	Wang, Y, Bu, F, Royer, C, Serres, S, Larkin, JR, Soto, MS, Sibson, N, Salter, V, Fritzsche, F, Turnquist, C, Koch, S, Zak, J, Zhong, S, Wu, G, Liang, A, Olofsen, P, Moch, H, Hancock, D, Downward, J, Goldin, R, Zhao, J, Tong, X, Guo, Y, Lu, X
Format:	Journal article
Language:	English
Published:	Nature Publishing Group 2014

Similar Items

ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63.
by: Tordella, L, et al.
Published: (2013)

ASPP2 links the apical lateral polarity complex to the regulation of YAP activity in epithelial cells
by: Royer, C, et al.
Published: (2014)

Investigating the role of iASPP and ASPP2 in human carcinoma
by: Salter, V
Published: (2014)

The role of p53 and ASPP2 in neurodegenerative disease
by: Turnquist, C
Published: (2015)

ASPP1 and ASPP2: common activators of p53 family members.
by: Bergamaschi, D, et al.
Published: (2004)

Nuclear iASPP may facilitate prostate cancer progression.
by: Morris, E, et al.
Published: (2014)

Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification.
by: Notari, M, et al.
Published: (2011)

ASPP [corrected] and cancer.
by: Trigiante, G, et al.
Published: (2006)

ASPP2 maintains the integrity of mechanically stressed pseudostratified epithelia during morphogenesis
by: Royer, C, et al.
Published: (2022)

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells
by: Wang, Y, et al.
Published: (2013)

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells.
by: Wang, Y, et al.
Published: (2013)

ASPP1 and ASPP2 are new transcriptional targets of E2F.
by: Fogal, V, et al.
Published: (2005)

STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression.
by: Turnquist, C, et al.
Published: (2014)

Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma.
by: Zhao, J, et al.
Published: (2010)

Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
by: Bergamaschi, D, et al.
Published: (2005)

ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth.
by: Vives, V, et al.
Published: (2006)

ASPP2 links the apical lateral polarity complex to the regulation of YAP activity in epithelial cells.
by: Christophe Royer, et al.
Published: (2014-01-01)

Regulation of immunological tolerance by the p53-inhibitor iASPP
by: Akama-Garren, EH, et al.
Published: (2023)

Effect of iASPP RNAi vector transfection on apoptosis of MCF-7
by: Hou, L, et al.
Published: (2008)

The role of ASPP2 in intestinal homeostasis and tumourigenesis
by: Qin, X
Published: (2017)

Cell autonomous role of iASPP deficiency in causing cardiocutaneous disorders
by: Dedeić, Z, et al.
Published: (2018)

ASPP--Apoptotic specific regulator of p53.
by: Liu, Z, et al.
Published: (2005)

The role of ASPP2 in intestinal cell polarity and homeostasis
by: Morato Koch, S
Published: (2013)

ASPP proteins specifically stimulate the apoptotic function of p53.
by: Samuels-Lev, Y, et al.
Published: (2001)

ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer
by: Liu, D, et al.
Published: (2020)

Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells.
by: Liu, Z, et al.
Published: (2008)

ASPP: a new family of oncogenes and tumour suppressor genes.
by: Sullivan, A, et al.
Published: (2007)

The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization
by: Slee, EA, et al.
Published: (2004)

Cardiocutaneous syndrome is caused by aggregation of iASPP mutants
by: Lotz, R, et al.
Published: (2024)

ASPP2: a gene that controls life and death in vivo.
by: Vives, V, et al.
Published: (2006)

The ASPP family: deciding between life and death after DNA damage.
by: Slee, E, et al.
Published: (2003)

ASPP2 binds Par-3 and controls the polarity and proliferation of neural progenitors during CNS development.
by: Sottocornola, R, et al.
Published: (2010)

iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition
by: Chen, S, et al.
Published: (2019)

Phosphorylation of ASPP2 by RAS/MAPK pathway is critical for its full pro-apoptotic function
by: Godin-Heymann, N, et al.
Published: (2013)

ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome
by: Zak, J, et al.
Published: (2016)

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer
by: Miller, P, et al.
Published: (2023)

Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1.
by: Shi, Y, et al.
Published: (2011)

Regulation of immunological tolerance by the p53-inhibitor iASPP
by: Elliot H. Akama-Garren, et al.
Published: (2023-02-01)

ZEB2 reduction contributes to pre-eclampsia via Wnt/β-Catenin pathway
by: Yanxin Zhang, et al.
Published: (2024-11-01)

Inhibitory member of the apoptosis-stimulating proteins of the p53 family (iASPP) interacts with protein phosphatase 1 via a noncanonical binding motif.
by: Llanos, S, et al.
Published: (2011)